Context Therapeutics (6K9.F) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.09
-0.08
-0.06
-0.04

Details

Expected EPS
-0.094697578
Actual EPS
-0.07658999999999999
Surprise EPS
0.02
Surprise Percent
+19.12%

Description

⁨Context Therapeutics⁩ (⁦6K9.F⁩) has reported earnings of ⁦-0.07658999999999999⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts